Really interesting roundup, Andrii. What stands out is how AI is moving beyond individual discovery tools into the wider R&D ecosystem-from co-scientists and CRO workflows to clinical development.
At the same time, the reminder that biology and clinical translation-not the technology itself-remain the real test is especially important.
Thank you. Yes, the translational phase is the ultimate real-life battle... Technology is just that -- means of getting there. Like somebody once said to me jokingly: "Who cares how you discovered that drug to cure cancer, by AI or by praying to God -- as long as it works?" Of course, it is not as simple. Having an AI system that is proven to output great results is much better than serendipity, because it is then an asset class, which has value in its own right. But still the joke has truth to it too. The ultimate result is helping a patient in need; everything else is just mechanics of the business...
David Shaywitz in the TMR wrote a nice summary of the two pieces mentioned at the top of this report.
Perhaps you mean this one? https://www.aei.org/commentary/ai-in-drug-rd-at-last-the-end-of-the-beginning/
That’s the one-I thought it was in Luke Timmerman’s journal but I stand corrected.
Thanks for surfacing this, it is actually a great read that I missed.
Really interesting roundup, Andrii. What stands out is how AI is moving beyond individual discovery tools into the wider R&D ecosystem-from co-scientists and CRO workflows to clinical development.
At the same time, the reminder that biology and clinical translation-not the technology itself-remain the real test is especially important.
Thank you. Yes, the translational phase is the ultimate real-life battle... Technology is just that -- means of getting there. Like somebody once said to me jokingly: "Who cares how you discovered that drug to cure cancer, by AI or by praying to God -- as long as it works?" Of course, it is not as simple. Having an AI system that is proven to output great results is much better than serendipity, because it is then an asset class, which has value in its own right. But still the joke has truth to it too. The ultimate result is helping a patient in need; everything else is just mechanics of the business...